Daily texting effectively monitors Rx adherence, side effects

May 30, 2017

(HealthDay)—For patients with breast cancer receiving endocrine therapy, daily bidirectional text messaging can monitor adherence and adverse events (AEs), according to a study published online May 23 in JCO: Clinical Cancer Informatics.

Sarah S. Mougalian, M.D., from the Yale University School of Medicine in New Haven, Conn., and colleagues developed a bidirectional application to track adherence, record symptoms, and alert the clinical team to therapy-related AEs. The intervention, which was piloted in 100 patients, included text messages to which patients responded for three months, assessing adherence, medication-related AEs, and barriers to adherence on a daily, weekly, and monthly basis. Eighty-nine patients completed the intervention.

The researchers found that 98 percent of patients reported that the intervention was easy to use and 96 percent reported that it was helpful for taking medication. Overall, four patients discontinued therapy before three months; of those who continued, 93 percent took ≥80 percent of their medication. The frequency of hot flashes, arthralgias, and vaginal symptoms as AEs reported via text messages was higher than that reported in clinical trials (72, 53, and 35 percent, respectively). About 39 percent of reported one or more severe AE, triggering an alert to the provider team who then contacted the patient.

"AEs of , as detected using this texting approach, are more prevalent than reported in ," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Review: mHealth text messages promote medication adherence

More information: Abstract
Full Text

Related Stories

Review: mHealth text messages promote medication adherence

August 3, 2015
(HealthDay)—Mobile health (mHealth) short message service text messages can improve medication adherence, according to a review published online July 27 in the Journal of Clinical Nursing.

Daily text messaging ups ART adherence in youth

December 20, 2016
(HealthDay)—A two-way, personalized daily text messaging intervention can improve antiretroviral therapy (ART) adherence among HIV-positive adolescents and young adults, according to a study published in AIDS and Behavior.

Baseline depression symptoms tied to low med adherence

July 18, 2016
(HealthDay)—Among clinical and sociodemographic characteristics, only baseline depressive symptoms are tied to low medication adherence in teen patients with type 2 diabetes, according to a study published online June 28 ...

Does text messaging help with medication adherence in chronic disease?

February 1, 2016
Medication adherence in chronic disease is poor. Can telephone text messaging help with adherence? A new article published online by JAMA Internal Medicine examines the question in a meta-analysis conducted by Jay Thakkar, ...

Children, parents over-report leukemia treatment adherence

February 2, 2017
New research suggests that young patients with acute lymphocytic leukemia (ALL)—the most common type of pediatric cancer—and their and their parents are likely to report to their physician that they took more of their ...

Pharmacist program can improve IFN-beta adherence in MS

May 17, 2017
(HealthDay)—A pharmacist medication adherence program can improve adherence to interferon-beta (IFN-β) among patients with relapsing-remitting multiple sclerosis (RRMS), according to a letter to the editor published online ...

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.